Form 4: Veracyte Director Jens Holstein Sells Shares Under 10b5-1 Plan
SEC Form 4
Director Jens Holstein of Veracyte, Inc. executed sales of common stock on August 7, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On August 7, 2024, Jens Holstein, a director of Veracyte, Inc. (VCYT), sold 2,500 shares of common stock at $28 per share and another 2,500 shares at $30 per share.
- These transactions were executed under a Rule 10b5-1 trading plan adopted on March 11, 2024.
- Following these sales, Holstein directly owns 27,878 shares of Veracyte common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a routine transaction under a pre-arranged trading plan.
Industry Context
Sales by company directors are a normal part of corporate governance. The fact that these sales were executed under a 10b5-1 plan suggests they were pre-planned and not based on any immediate inside information.
Stakeholder Impact
- The sale of shares by a director could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| March 11, 2024 | Date the reporting person adopted the Rule 10b5-1 plan |
| August 07, 2024 | Date of the stock sale transactions |
| August 09, 2024 | Date of the signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.